Diffuse large B-cell lymphoma trials in Georgia
2 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 1/2RecruitingTrial-stage medicine
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Tbilisi
- Age
- 18 years and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716EU 2022-502157-33-00Registry updated 2026-10-05
Phase 1RecruitingTrial-stage medicine
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
- Where
- Tbilisi
- Age
- 18 years and over
- People
- 85 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT06980116EU 2024-516869-36-00Registry updated 2026-08-13
All Diffuse large B-cell lymphoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.